Christian Dallaire

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

LR Sutherland, Florian Martin, RJ Bailey et al. · Gastroenterology · 1997 · 167 citations

Disease Study Group, Double-blind Trial, Gastroenterology +4

Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial

Stephen B. Hanauer, William J. Sandborn, Christian Dallaire et al. · Canadian Journal of Gastroenterology · 2007 · 164 citations · Full text

Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting

Gervais Tougas, Ying Chen, Geoffrey Coates et al. · The American Journal of Gastroenterology · 2000 · 109 citations